500 patients67,039 observations150 daysLIVE

Patient P-03407

Synthetic patientONX-7 · Day 139 · 65–74 · M · baseline S20Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
9%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S20

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Nutritional resilience+13
  • GI instability-12
  • Toxicity-11
  • Inflammatory activity-7
  • Treatment adherence+4

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Energy level
    Daily log
    5.9/10
    improving · +0.4 vs previous 14 d
    Stress level
    Daily log
    3.1/10
    improving · -0.3 vs previous 14 d
    Pessimism score
    Daily log
    3.5/10
    stable · +0.1 vs previous 14 d
    Sleep quality
    Wearable
    56.4/100
    improving · +2.9 vs previous 14 d
    Libido
    Daily log
    5.3/10
    improving · +0.3 vs previous 14 d
    HRV
    Wearable
    50.3 ms
    stable · +1.7 vs previous 14 d
    Toxicity
    Blood
    15.7/100
    stable · -0.3 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 78 from the failing basin, 25 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +9.2
    • Butyrate producers intact
      hidden · steering +7.5
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -4.3 next day
    Main detractors to watch
    • Antibiotic course
      perturbation · steering -4.7
    • Poor-sleep week
      perturbation · steering -3
    • Low-HRV stretch
      perturbation · steering -2.7
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -4.3supporter · 95%
    • Alcohol
      +1.7no signal · 50%
    • Dietary fat load
      +0.5no signal · 15%
    • Histamine load
      +0.4no signal · 15%
    • Lactose
      +0.3no signal · 15%
    • Caffeine
      -0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 25
      • MicrobiomeF. prausnitzii depleted
    • Autonomic recovery 25
      • WearableResting HR 75 bpm
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 3.6 · butyrate capacity 75/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    47 ms
    Sleep
    7.4 h
    Steps
    5,549
    Resting HR
    74 bpm
    Daily log: GI score 14, nutritional resilience 69, adherence 94.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0310550%S12AD-05no change60
    P-0348240%S05AD-05no change67
    P-0320436%S16AD-05improved48
    P-0335135%S07AD-05no change51
    P-0342434%S12AD-05improved41
    P-0344134%S19AD-05improved37
    P-0311133%S07AD-05no change48
    P-0312933%S18AD-05no change32
    P-0318733%S12AD-05no change80
    P-0338033%S16AD-05improved34
    P-0336932%S18AD-05no change37
    P-0312231%S13AD-05no change40